Chemical Structure (Fludeoxyglucose 01)
Fludeoxyglucose F-18 Injection
Product Images NDC 78714-001
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fludeoxyglucose F-18 (NDC 78714-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Barbara Ann Karmanos Cancer Hospital, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (30 mL Glass Vial Label)
Fludeoxvglucose F 18 Injection is a sterile, non-pyrogenic, radioactive material used for diagnostic purposes. It comes in a multiple-dose vial containing 0.74-11.1 GBq (20-300 mCilmL) of no-carrier added Fludeoxyglucose F 18 (2-deaxy-2-[*F]fluoro-D-glucose) @ EOS*and 4.5 mg of sodium chloride in citrate buffer per mL. It should not be used if it is cloudy or if it contains particulate matter. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). The item has a shelf life of 109.8 minutes, and the correct dosage should be calculated from the date and time of calibration. This product is for intravenous use only and is intended for diagnostic purposes. Karuanos Cancer nsings in Detroit, MI, is the vendor of this product.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
